Top news
Johnson & Johnson vaccine should be paused in U.S. after 'extremely rare' blood clots, FDA and CDC say
By Erika Edwards, Alexander Smith & Amanda Golden
CDC, FDA To Review J&J Shot After 6 Blood Clot Cases Reported Out Of Nearly 7M Doses
By Scott Neuman
FDA advises states to pause use of J&J Covid vaccine after rare blood-clotting issue affects 6 women, kills 1
By Berkeley Lovelace, Berkeley Lovelace Jr. & Dawn Kopecki
All coverage
Johnson & Johnson vaccine deliveries plunge as company backs off previous April target
By Christopher Rowland
Georgia becomes third state to shut down Johnson & Johnson vaccine site after adverse reactions
By Nikki Battiste
U.S. Calls for Pause on Johnson & Johnson Vaccine After Blood Clotting Cases
By Sharon LaFraniere, Carl Zimmer & Noah Mercer Weiland
Johnson & Johnson vaccine paused over rare blood clots
By Rachel Schraer
FDA, CDC call for pause in use of Johnson & Johnson vaccine after 'extremely rare' cases of blood clots
By Lena Sun, Carolyn Johnson & Laurie McGinley